Table 4 Comparison between treated and control groups (no of glands per patients).

Initial biopsies	No of glands	Repeat biopsies
		Monofocal HGPIN	Plurifocal HGPIN
Monofocal HGPIN
Treated group	2 (1–4)*	2	0
Controls	2 (1–4)*	2 (1–3)*	0
Plurifocal HGPIN
Treated group	5 (3–8)*	3	0
Controls	6 (3–9)*	0	7 (4–9)*

HGPIN, high‐grade prostatic intraepithelial neoplasia;

*Mean and range